207 related articles for article (PubMed ID: 22556422)
1. Matrix disruptions, growth, and degradation of cartilage with impaired sulfation.
Mertz EL; Facchini M; Pham AT; Gualeni B; De Leonardis F; Rossi A; Forlino A
J Biol Chem; 2012 Jun; 287(26):22030-42. PubMed ID: 22556422
[TBL] [Abstract][Full Text] [Related]
2. Defective proteoglycan sulfation of the growth plate zones causes reduced chondrocyte proliferation via an altered Indian hedgehog signalling.
Gualeni B; Facchini M; De Leonardis F; Tenni R; Cetta G; Viola M; Passi A; Superti-Furga A; Forlino A; Rossi A
Matrix Biol; 2010 Jul; 29(6):453-60. PubMed ID: 20470884
[TBL] [Abstract][Full Text] [Related]
3. Proteoglycan sulfation in cartilage and cell cultures from patients with sulfate transporter chondrodysplasias: relationship to clinical severity and indications on the role of intracellular sulfate production.
Rossi A; Kaitila I; Wilcox WR; Rimoin DL; Steinmann B; Cetta G; Superti-Furga A
Matrix Biol; 1998 Oct; 17(5):361-9. PubMed ID: 9822202
[TBL] [Abstract][Full Text] [Related]
4. Undersulfation of cartilage proteoglycans ex vivo and increased contribution of amino acid sulfur to sulfation in vitro in McAlister dysplasia/atelosteogenesis type 2.
Rossi A; Bonaventure J; Delezoide AL; Superti-Furga A; Cetta G
Eur J Biochem; 1997 Sep; 248(3):741-7. PubMed ID: 9342225
[TBL] [Abstract][Full Text] [Related]
5. A diastrophic dysplasia sulfate transporter (SLC26A2) mutant mouse: morphological and biochemical characterization of the resulting chondrodysplasia phenotype.
Forlino A; Piazza R; Tiveron C; Della Torre S; Tatangelo L; Bonafè L; Gualeni B; Romano A; Pecora F; Superti-Furga A; Cetta G; Rossi A
Hum Mol Genet; 2005 Mar; 14(6):859-71. PubMed ID: 15703192
[TBL] [Abstract][Full Text] [Related]
6. In vivo contribution of amino acid sulfur to cartilage proteoglycan sulfation.
Pecora F; Gualeni B; Forlino A; Superti-Furga A; Tenni R; Cetta G; Rossi A
Biochem J; 2006 Sep; 398(3):509-14. PubMed ID: 16719839
[TBL] [Abstract][Full Text] [Related]
7. Maintenance of chondroitin sulfation balance by chondroitin-4-sulfotransferase 1 is required for chondrocyte development and growth factor signaling during cartilage morphogenesis.
Klüppel M; Wight TN; Chan C; Hinek A; Wrana JL
Development; 2005 Sep; 132(17):3989-4003. PubMed ID: 16079159
[TBL] [Abstract][Full Text] [Related]
8. Alteration of proteoglycan sulfation affects bone growth and remodeling.
Gualeni B; de Vernejoul MC; Marty-Morieux C; De Leonardis F; Franchi M; Monti L; Forlino A; Houillier P; Rossi A; Geoffroy V
Bone; 2013 May; 54(1):83-91. PubMed ID: 23369989
[TBL] [Abstract][Full Text] [Related]
9. Identification of potential non-invasive biomarkers in diastrophic dysplasia.
Paganini C; Carroll RS; Gramegna Tota C; Schelhaas AJ; Leone A; Duker AL; O'Connell DA; Coghlan RF; Johnstone B; Ferreira CR; Peressini S; Albertini R; Forlino A; Bonafé L; Campos-Xavier AB; Superti-Furga A; Zankl A; Rossi A; Bober MB
Bone; 2023 Oct; 175():116838. PubMed ID: 37454964
[TBL] [Abstract][Full Text] [Related]
10. Insights from a transgenic mouse model on the role of SLC26A2 in health and disease.
Forlino A; Gualeni B; Pecora F; Della Torre S; Piazza R; Tiveron C; Tatangelo L; Superti-Furga A; Cetta G; Rossi A
Novartis Found Symp; 2006; 273():193-206; discussion 206-12, 261-4. PubMed ID: 17120769
[TBL] [Abstract][Full Text] [Related]
11. N-acetylcysteine treatment ameliorates the skeletal phenotype of a mouse model of diastrophic dysplasia.
Monti L; Paganini C; Lecci S; De Leonardis F; Hay E; Cohen-Solal M; Villani S; Superti-Furga A; Tenni R; Forlino A; Rossi A
Hum Mol Genet; 2015 Oct; 24(19):5570-80. PubMed ID: 26206888
[TBL] [Abstract][Full Text] [Related]
12. Improvement of the skeletal phenotype in a mouse model of diastrophic dysplasia after postnatal treatment with N-acetylcysteine.
Paganini C; Gramegna Tota C; Monti L; Monti I; Maurizi A; Capulli M; Bourmaud M; Teti A; Cohen-Solal M; Villani S; Forlino A; Superti-Furga A; Rossi A
Biochem Pharmacol; 2021 Mar; 185():114452. PubMed ID: 33545117
[TBL] [Abstract][Full Text] [Related]
13. Multiple roles of the SO4(2-)/Cl-/OH- exchanger protein Slc26a2 in chondrocyte functions.
Park M; Ohana E; Choi SY; Lee MS; Park JH; Muallem S
J Biol Chem; 2014 Jan; 289(4):1993-2001. PubMed ID: 24302720
[TBL] [Abstract][Full Text] [Related]
14. In vitro proteoglycan sulfation derived from sulfhydryl compounds in sulfate transporter chondrodysplasias.
Rossi A; Cetta G; Piazza R; Bonaventure J; Steinmann B; Supereti-Furga A
Pediatr Pathol Mol Med; 2003; 22(4):311-21. PubMed ID: 14692227
[TBL] [Abstract][Full Text] [Related]
15. Altered signaling in the G1 phase deregulates chondrocyte growth in a mouse model with proteoglycan undersulfation.
De Leonardis F; Monti L; Gualeni B; Tenni R; Forlino A; Rossi A
J Cell Biochem; 2014 Oct; 115(10):1779-86. PubMed ID: 24820054
[TBL] [Abstract][Full Text] [Related]
16. Undersulfation of proteoglycans synthesized by chondrocytes from a patient with achondrogenesis type 1B homozygous for an L483P substitution in the diastrophic dysplasia sulfate transporter.
Rossi A; Bonaventure J; Delezoide AL; Cetta G; Superti-Furga A
J Biol Chem; 1996 Aug; 271(31):18456-64. PubMed ID: 8702490
[TBL] [Abstract][Full Text] [Related]
17. Sulfation of chondroitin sulfate proteoglycans is necessary for proper Indian hedgehog signaling in the developing growth plate.
Cortes M; Baria AT; Schwartz NB
Development; 2009 May; 136(10):1697-706. PubMed ID: 19369399
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene (SLC26A2): 22 novel mutations, mutation review, associated skeletal phenotypes, and diagnostic relevance.
Rossi A; Superti-Furga A
Hum Mutat; 2001 Mar; 17(3):159-71. PubMed ID: 11241838
[TBL] [Abstract][Full Text] [Related]
19. Tyrosinase-crosslinked, tissue adhesive and biomimetic alginate sulfate hydrogels for cartilage repair.
Öztürk E; Stauber T; Levinson C; Cavalli E; Arlov Ø; Zenobi-Wong M
Biomed Mater; 2020 Jun; 15(4):045019. PubMed ID: 32578533
[TBL] [Abstract][Full Text] [Related]
20. A compound heterozygote of novel and recurrent DTDST mutations results in a novel intermediate phenotype of Desbuquois dysplasia, diastrophic dysplasia, and recessive form of multiple epiphyseal dysplasia.
Miyake A; Nishimura G; Futami T; Ohashi H; Chiba K; Toyama Y; Furuichi T; Ikegawa S
J Hum Genet; 2008; 53(8):764-768. PubMed ID: 18553123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
